Featured
Alzheimer's Drug Leqembi Shows Promise in Real-World Study, Stabilizing Over 75% of Patients
A groundbreaking real-world study presented at the 2026 Alzheimer’s Association International Conference reveals that the anti-amyloid therapy Leqem...
Read Full Story →